Detail akcie Agilent Tech online

Business Summary: Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers services portfolio, which includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the laboratory operations.
Financial Summary: BRIEF: For the six months ended 30 April 2024, Agilent Technologies Inc revenues decreased 7% to $3.23B. Net income increased less than 1% to $656M. Revenues reflect Life Sciences and Applied Markets segment decrease of 58% to $846M, Agilent CrossLab segment decrease of 47% to $405M, Diagnostics and Genomics segment decrease of 42% to $407M, United States segment decrease of 54% to $630M, Asia Pacific segment decrease of 53% to $570M.